As cell models, we used ex vivo samples from patients and also selected the in vitro CLL cell line Mec-1, generating two sub-lines overexpressing Bcl-XL and Mcl-1, a common feature in this cancer. This evidence concerns the gene BCL2L1 and B-cell chronic lymphocytic leukemia.